<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="http://www.physorg.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0">
<channel>
<title>PHYSorg.com: PHYSorg news tagged with: pancreatic</title>
<link>http://www.physorg.com/</link>
<language>en-us</language> 
<description>Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>Pancreatic fat levels may help predict diabetes, researchers say</title>
   	 <description>Researchers have long suspected that overweight people tend to have large fat deposits in their pancreases, but they've been unable to confirm or calculate how much fat resides there because of the organ's location.</description>
     <link>http://www.physorg.com/news172819152.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 22 Sep 2009 06:40:02 EST</pubDate>
	 <guid isPermaLink="false">news172819152</guid>
</item>
<item>
     <title>Endothelin-1 inhibitors in chronic pancreatitis</title>
   	 <description>Fibrosis is a key feature of chronic pancreatitis and pancreatic cancer. The extensive deposition of extracellular matrix proteins fosters the development of an exocrine and endocrine organ insufficiency, and accelerates progression of the tumour. Pancreatic stellate cells (PSC) are the principal effector cells in pancreatic fibrosis. They are activated by profibrogenic mediators, which include, for example, cytokines and ethanol metabolites. So far, there are no therapies available to interfere with fibrogenesis in the diseased organ.</description>
     <link>http://www.physorg.com/news172397446.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 17 Sep 2009 09:12:01 EST</pubDate>
	 <guid isPermaLink="false">news172397446</guid>
</item>
<item>
     <title>Imaging features of intraductal papillary mucinous neoplasms of the pancreas</title>
   	 <description>The intraductal papillary mucinous neoplasms (IPMN) can evolve through all biological stages, from slight dysplasia to carcinoma. As one of the few surgically curable pancreatic tumors, accurate preoperative prediction of malignancy remains one of the major issues in the optimal treatment of IPMNs, and it also influences the outcome of the resection.</description>
     <link>http://www.physorg.com/news172311550.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 16 Sep 2009 09:30:01 EST</pubDate>
	 <guid isPermaLink="false">news172311550</guid>
</item>
<item>
     <title>Team reveals molecular mechanism underlying a form of diabetes</title>
   	 <description>By investigating a rare and severe form of diabetes in children, University of Iowa researchers have discovered a new molecular mechanism that regulates specialized pancreatic cells and insulin secretion. The mechanism involves a protein called ankyrin, which UI researchers previously linked to potentially fatal human heart arrhythmias.</description>
     <link>http://www.physorg.com/news171634645.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 08 Sep 2009 13:17:54 EST</pubDate>
	 <guid isPermaLink="false">news171634645</guid>
</item>
<item>
     <title>Malignant signature may help identify patients likely to respond to therapy</title>
   	 <description>A molecular signature that helps account for the aggressive behavior of a variety of cancers such as pancreatic, breast and melanoma may also predict the likelihood of successful treatment with a particular anti-cancer drug. The finding, which could lead to a personalized approach to treatment for a variety of solid tumors that are currently resistant to therapies, will be published September 6 in the advance online edition of Nature Medicine.</description>
     <link>http://www.physorg.com/news171462152.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Sun, 06 Sep 2009 13:23:38 EST</pubDate>
	 <guid isPermaLink="false">news171462152</guid>
</item>
<item>
     <title>Pancreatic cancer affects blacks at higher rates</title>
   	 <description>Regardless of risk factors linked to pancreatic cancer, such as smoking and body mass index (BMI), blacks experienced higher rates of pancreatic cancer death than whites.</description>
     <link>http://www.physorg.com/news171031591.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 01 Sep 2009 14:00:01 EST</pubDate>
	 <guid isPermaLink="false">news171031591</guid>
</item>
<item>
     <title>Does the distance a patient has to travel affect where they choose to get their care?</title>
   	 <description>Do patients choose where to get their care based on how long it takes to them to get there?  Researchers at Fox Chase Cancer Center have recently documented a growing trend in the centralization of cancer surgery -more patients seeking care at high volume centers, which are generally located in metropolitan areas.  While trends like this should improve patient outcomes, a study published in the Journal of Clinical Oncology shows that there are still a good number of patients who will not travel a long distance to get their care.</description>
     <link>http://www.physorg.com/news170960897.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 31 Aug 2009 18:40:04 EST</pubDate>
	 <guid isPermaLink="false">news170960897</guid>
</item>
<item>
     <title>New initiative to develop modeling tools for disease and complex systems</title>
   	 <description>A multidisciplinary team led by Carnegie Mellon University computer scientist Edmund M. Clarke has received a five-year, $10 million grant from the National Science Foundation's Expeditions in Computing program to create revolutionary computational tools that will advance science on a broad array of fronts, from discovering new cancer treatments to designing safer aircraft.</description>
     <link>http://www.physorg.com/news169890411.html</link>
	 <category>Technology</category>
	 <pubDate>Wed, 19 Aug 2009 09:00:04 EST</pubDate>
	 <guid isPermaLink="false">news169890411</guid>
</item>
<item>
     <title>Prion protein identified as a novel early pancreatic cancer biomarker</title>
   	 <description>Mad cow disease is caused by the accumulation of an abnormal protein, the prion, in the brain of an affected patient. Outside of the brain, very little is known about prions. Case Western Reserve University School of Medicine, researchers have, for the first time, identified the prion as a biomarker for pancreatic cancer. Pancreatic cancer is one of the most deadly cancers in humans; the five year survival rate is less than 10 percent.</description>
     <link>http://www.physorg.com/news169751882.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 17 Aug 2009 22:50:01 EST</pubDate>
	 <guid isPermaLink="false">news169751882</guid>
</item>
<item>
     <title>New study expands the list of hazardous chemicals in smokeless tobacco</title>
   	 <description>Attention all smokeless tobacco users!  It's time to banish the comforting notion that snuff and chewing tobacco are safe because they don't burn and produce inhalable smoke like cigarettes. A study that looked beyond the well-researched tobacco hazards, nitrosamines and nicotine, has discovered a single pinch -- the amount in a portion -- of smokeless tobacco exposes the user to the same amount of another group of dangerous chemicals as the smoke of five cigarettes.</description>
     <link>http://www.physorg.com/news169644304.html</link>
	 <category>Chemistry</category>
	 <pubDate>Sun, 16 Aug 2009 12:40:01 EST</pubDate>
	 <guid isPermaLink="false">news169644304</guid>
</item>
<item>
     <title>New tool may help with early detection of deadly pancreatic cancer</title>
   	 <description>A new diagnostic tool developed by Van Andel Research Institute (VARI) scientists has shown promising results when used with patients of pancreatic cancer, one of the deadliest forms of cancer due to the difficulty of diagnosing it in its early stages. The method, which studies carbohydrate structures in the bloodstream, could lead to the development of blood tests that can detect cancer more effectively.</description>
     <link>http://www.physorg.com/news168526022.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 03 Aug 2009 14:00:02 EST</pubDate>
	 <guid isPermaLink="false">news168526022</guid>
</item>
<item>
     <title>Common diabetic therapy reduces risk of pancreatic cancer, study finds</title>
   	 <description>Taking the most commonly-prescribed anti-diabetic drug, metformin, reduces an individual's risk of developing pancreatic cancer by 62 percent, according to research from The University of Texas M. D. Anderson Cancer Center, published in the Aug. 1 issue of Gastroenterology.</description>
     <link>http://www.physorg.com/news168324813.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Sat, 01 Aug 2009 09:00:01 EST</pubDate>
	 <guid isPermaLink="false">news168324813</guid>
</item>
<item>
     <title>Smoking increases potential for metastatic pancreatic cancer</title>
   	 <description>Smoking has once again been implicated in the development of advanced cancer. Exposure to nicotine by way of cigarette smoking may increase the likelihood that pancreatic ductal adenocarcinoma will become metastatic, according to researchers from the Kimmel Cancer Center at Jefferson. Their study was published in the August edition of the journal Surgery.</description>
     <link>http://www.physorg.com/news167922110.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 27 Jul 2009 14:30:02 EST</pubDate>
	 <guid isPermaLink="false">news167922110</guid>
</item>
<item>
     <title>Discovery of genetic toggle switch inches closer to possible diabetes cure</title>
   	 <description>Scientists have identified a master regulator gene for early embryonic development of the pancreas and other organs, putting researchers closer to coaxing stem cells into pancreatic cells as a possible cure for type1 diabetes.</description>
     <link>http://www.physorg.com/news167311578.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 20 Jul 2009 12:50:01 EST</pubDate>
	 <guid isPermaLink="false">news167311578</guid>
</item>
<item>
     <title>New drug candidate prolongs the lives of pancreatic cancer patients</title>
   	 <description>Every year, 42,000 Americans are diagnosed with pancreatic cancer. Few live very long, and less than 5% are still alive five years after diagnosis.</description>
     <link>http://www.physorg.com/news167310392.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 20 Jul 2009 12:30:01 EST</pubDate>
	 <guid isPermaLink="false">news167310392</guid>
</item>
<item>
     <title>Enhancement of pancreatic cancer on dynamic CT:  Does it correlate with angiogenesis and fibrosis?</title>
   	 <description>Prognosis of pancreatic cancer is poor. Recently, it has been clarified that the grade of tumor angiogenesis is a useful prognostic marker in human cancer, including pancreatic cancer. To establish the grade of tumor angiogenesis by non-invasive imaging may be important clinically. However, there are only a few such reports on pancreatic cancer.</description>
     <link>http://www.physorg.com/news166968779.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 16 Jul 2009 13:17:44 EST</pubDate>
	 <guid isPermaLink="false">news166968779</guid>
</item>
<item>
     <title>Study could help target new pancreatitis treatments</title>
   	 <description>Pancreatitis is often a fatal condition, in which the pancreas digests itself and surrounding tissue.  Scientists have previously found that alcohol can trigger the condition by combining with fatty acids in the pancreas, which leads to an excessive release of stored calcium ions.  Once calcium ions enter cell fluid in the pancreas it activates digestive enzymes and damages the cells.</description>
     <link>http://www.physorg.com/news165489834.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 29 Jun 2009 10:40:03 EST</pubDate>
	 <guid isPermaLink="false">news165489834</guid>
</item>
<item>
     <title>Dietary fat linked to pancreatic cancer</title>
   	 <description>High intake of dietary fats from red meat and dairy products was associated with an increased risk of pancreatic cancer, according to a new study published online June 26 in the Journal of the National Cancer Institute.</description>
     <link>http://www.physorg.com/news165255064.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 26 Jun 2009 17:11:34 EST</pubDate>
	 <guid isPermaLink="false">news165255064</guid>
</item>
<item>
     <title>Study finds strong relationship between high body mass index, pancreatic cancer</title>
   	 <description>In reviewing the weight history of pancreatic cancer patients across their life spans, researchers at The University of Texas M. D. Anderson Cancer Center have determined that a high body mass index in early adulthood may play a significant role in an individual developing the disease at an earlier age.</description>
     <link>http://www.physorg.com/news164994503.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 23 Jun 2009 16:49:15 EST</pubDate>
	 <guid isPermaLink="false">news164994503</guid>
</item>
<item>
     <title>Adenoviral vector specifically targeted to EphA2 receptor in pancreatic cancer cells</title>
   	 <description>Pancreatic cancer is a devastating disease with poor prognosis. This warrants the development of novel therapies including gene therapy. However, clinical studies have demonstrated poor efficacy of adenoviral gene therapy because of the absence of adenoviral binding sites on pancreatic cancer cells such as the coxsackie and adenovirus receptor (CAR). Circumventing CAR-mediated entry therefore seems a promising option to improve adenoviral entry into pancreatic cancer cells and to enhance the efficacy of adenoviral vectors.</description>
     <link>http://www.physorg.com/news164977499.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 23 Jun 2009 12:06:32 EST</pubDate>
	 <guid isPermaLink="false">news164977499</guid>
</item>
<item>
     <title>Variability in pancreatic cancer care found with newly developed quality indicators</title>
   	 <description>A set of expert consensus-based, quality-of-care indicators identified considerable variability in the quality of pancreatic cancer care among hospitals and may be used to evaluate and identify areas for improvement, according to a new study in the June 9 online issue of the Journal of the National Cancer Institute.</description>
     <link>http://www.physorg.com/news163822485.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 10 Jun 2009 03:15:36 EST</pubDate>
	 <guid isPermaLink="false">news163822485</guid>
</item>
<item>
     <title>Researchers identify critical marker of response to gemcitabine in pancreatic cancer</title>
   	 <description>A protein related to aggressive cancers can actually improve the efficacy of gemcitabine at treating pancreatic cancer, according to a Priority Report in Cancer Research, published by researchers at Thomas Jefferson University.</description>
     <link>http://www.physorg.com/news163331753.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 04 Jun 2009 10:56:19 EST</pubDate>
	 <guid isPermaLink="false">news163331753</guid>
</item>
<item>
     <title>New pathology tests double sensitivity to detect bile duct and pancreatic cancers</title>
   	 <description>Pancreatic cancer and bile duct cancer are difficult to diagnose and often fatal because they are discovered in the advanced stages of the disease. Researchers have developed new tests that double the ability to detect bile duct and pancreatic cancers, according to a Mayo Clinic study published in the June issue of Gastroenterology.</description>
     <link>http://www.physorg.com/news163061370.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 01 Jun 2009 07:49:53 EST</pubDate>
	 <guid isPermaLink="false">news163061370</guid>
</item>
<item>
     <title>Popular diabetes treatment could trigger pancreatitis, pancreatic cancer</title>
   	 <description>A drug widely used to treat Type 2 diabetes may have unintended effects on the pancreas that could lead to a form of low-grade pancreatitis in some patients and a greater risk of pancreatic cancer in long-term users, UCLA researchers have found. </description>
     <link>http://www.physorg.com/news160326333.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 30 Apr 2009 16:05:54 EST</pubDate>
	 <guid isPermaLink="false">news160326333</guid>
</item>
<item>
     <title>Type of connection procedure after pancreatic surgery influenced rate of pancreatic fistula</title>
   	 <description>After surgery to remove the head of the pancreas, invagination of the pancreas into the small intestine resulted in a lower rate of pancreatic fistula, according to researchers at the Jefferson Pancreas, Biliary and Related Cancer Center. The research was published in the Journal of the American College of Surgeons. It was performed as a randomized trial - the gold standard for studies.</description>
     <link>http://www.physorg.com/news160311885.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 30 Apr 2009 12:05:22 EST</pubDate>
	 <guid isPermaLink="false">news160311885</guid>
</item>
<item>
     <title>Charred meat may increase risk of pancreatic cancer</title>
   	 <description>Meat cooked at high temperatures to the point of burning and charring may increase the risk of pancreatic cancer, according to data presented at the American Association for Cancer Research 100th Annual Meeting 2009.</description>
     <link>http://www.physorg.com/news159559671.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 21 Apr 2009 19:08:35 EST</pubDate>
	 <guid isPermaLink="false">news159559671</guid>
</item>
<item>
     <title>Researchers Formulate Treatment Combination Lethal To Pancreatic Cancer Cells (w/Video)</title>
   	 <description>A combination of two targeted therapies packs a powerful punch to kill pancreatic cancer cells in the laboratory, Mayo Clinic cancer researchers report. With further testing of these drugs that are from classes of pharmaceuticals already used in patients, the Mayo research may lead to new treatment opportunities for patients with pancreatic cancer, which is extremely difficult to treat.</description>
     <link>http://www.physorg.com/news159439961.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 20 Apr 2009 09:53:09 EST</pubDate>
	 <guid isPermaLink="false">news159439961</guid>
</item>
<item>
     <title>An herbal extract inhibits the development of pancreatic cancer</title>
   	 <description>An herb recently found to kill pancreatic cancer cells also appears to inhibit development of pancreatic cancer as a result of its anti-inflammatory properties, according to researchers from the Kimmel Cancer Center at Jefferson. The data were presented at the AACR 100th Annual Meeting 2009 in Denver.</description>
     <link>http://www.physorg.com/news159371846.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Sun, 19 Apr 2009 14:58:19 EST</pubDate>
	 <guid isPermaLink="false">news159371846</guid>
</item>
<item>
     <title>Newly discovered epidermal growth factor receptor active in human pancreatic cancers</title>
   	 <description>Finally some promising news about pancreatic cancer, one of the most fatal cancers, due to the difficulties of early detection and the lack of effective therapies: Johns Hopkins University pathologist Akhilesh Pandey has identified an epidermal growth factor receptor aberrantly active in approximately a third of the 250 human pancreatic cancers studied.</description>
     <link>http://www.physorg.com/news159370670.html</link>
	 <category>Biology</category>
	 <pubDate>Sun, 19 Apr 2009 14:38:20 EST</pubDate>
	 <guid isPermaLink="false">news159370670</guid>
</item>
<item>
     <title>Experimental insulin-like growth factor receptor inhibitor reduced pancreatic cancer growth</title>
   	 <description>Researchers at Amgen are testing a fully human monoclonal antibody that inhibits the activity of insulin-like growth factors (IGF-1 and IGF-2) and appears to reduce pancreatic cancer cells in early testing, according to a report in Molecular Cancer Therapeutics, a journal of the American Association for Cancer Research.</description>
     <link>http://www.physorg.com/news158936367.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 14 Apr 2009 14:00:10 EST</pubDate>
	 <guid isPermaLink="false">news158936367</guid>
</item>


</channel>
</rss>

